ROS1 Test in Lung Cancer: Who Needs It and Why?

On this page
ROS1 Testing in Lung Cancer: What It Means and Why It Matters
ROS1 testing looks for a particular genetic alteration in lung cancer cells. Detecting a ROS1 rearrangement can make certain targeted therapies available, which is an important part of precision oncology, treatment tailored to the cancer’s unique genetic features.
What Is a ROS1 Test?
- The ROS1 gene helps regulate how cells grow and signal.
- Sometimes, part of ROS1 fuses with another gene, driving uncontrolled growth, a ROS1 rearrangement.
- This change is an “actionable biomarker,” meaning it can inform treatment decisions.
- ROS1-positive non-small cell lung cancer (NSCLC) may be treated with medicines targeting ROS1, sometimes instead of or alongside chemotherapy or other treatments.
Who Should Get ROS1 Testing?
- Most relevant for: Non-small cell lung cancer, especially adenocarcinoma; important in advanced or metastatic cases.
- Comprehensive molecular profiling is preferred to test for ROS1 and other key biomarkers (e.g., EGFR, ALK, KRAS, BRAF, RET, MET, HER2, NTRK) at the same time.
- The decision to order testing is based on:
- Cancer subtype
- Disease stage
- Previous treatments
- Tumor tissue availability
- Clinical judgment of the care team
How Is ROS1 Testing Done?
- Immunohistochemistry (IHC):Uses special stains to screen for ROS1 protein in tumor tissue; positives need molecular confirmation.
- Fluorescence In Situ Hybridization (FISH):Finds ROS1 gene rearrangements using labeled probes.
- Next-Generation Sequencing (NGS):Assesses ROS1 and other gene alterations in one test; conserves tissue.
- RT-PCR:May be used in certain labs for detecting gene fusions.
- Tissue-based testing:Preferred when a tumor biopsy is available.
- Liquid biopsy (blood test):Analyzes circulating tumor DNA; useful when tumor tissue can’t be safely obtained, though a negative blood test doesn’t completely rule out a ROS1 alteration.
Interpreting ROS1 Test Results
- ROS1-Positive:A fusion or rearrangement is found. Targeted therapy (ROS1 inhibitor) may be considered. Actual treatment also depends on stage, spread (including to the brain), prior therapies, and other biomarkers.
- ROS1-Negative:No ROS1 alteration detected. Other actionable biomarkers might still be present, so broad molecular profiling is still important.
- Inconclusive:Not enough tumor tissue, low blood tumor DNA, or technical test limitations. May require repeat testing or another biopsy.
ROS1 Testing and Lung Cancer Care
- Does NOT directly treat lung cancer, but helps the team select the most effective, least toxic therapy.
- Targeted therapies act specifically on molecular drivers like ROS1 rather than attacking all rapidly dividing cells (like chemo) or boosting the immune system (as immunotherapies do).
- Repeat molecular testing may be considered if cancer progresses after prior targeted therapy, to identify resistance and guide the next steps.
Key Takeaways ROS1 rearrangement is actionable in some non-small cell lung cancers. Testing is especially vital in advanced/metastatic cancers and key NSCLC subtypes. IHC, FISH, NGS, and other tests may be used, depending on context and sample availability. Tissue testing is the gold standard, but liquid biopsy can be a backup when tissue isn’t available. Positive ROS1 supports targeted therapy; negative does not rule out other options. Results must be interpreted alongside all clinical and pathology information by your oncology care team.
Common questions
Can ROS1 testing use blood?
Yes; liquid biopsy can help when tissue is unavailable, but a negative result may still need a tissue test for confirmation.
How is ROS1-positive lung cancer treated?
With ROS1 inhibitors and other targeted therapies, as determined by your care team and overall clinical situation.
What if the ROS1 test is inconclusive?
You may need a repeat test or a different tissue sample.
Should testing be repeated if cancer progresses?
Sometimes, especially to clarify the next best therapy, depending on your cancer’s behavior and prior treatments.

